Energy expenditure and indirect calorimetry in critical illness and convalescence: current evidence and practical considerations

Posted on 24 January 2021, Scientific

Energy expenditure and indirect calorimetry in critical illness and convalescence: current evidence and practical considerations

Energy expenditure appears highly variable among critically ill patients and in individual patients during various phases of illness. As a consequence, critically ill patients are at considerable risk of under- or overfeeding during ICU and post-ICU hospital stay, when rough and static estimates are used. The most recent international guidelines recommend regular indirect calorimetry to measure energy expenditure as a proxy for caloric requirement in ICU patients.

Review of evolution and current status of protein requirements and provision in acute illness and critical care

Posted on 10 January 2021, Scientific

American Journal of Respiratory and Critical Care Medicine

This review article summarizes current evidence supporting the role of higher protein intakes, especially during the early phases of nutrition therapy in acute illness, methods for assessing protein requirements, as well as, the currently available high-protein enteral and parenteral nutrition solutions. 

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

Posted on 14 February 2020, English, Company, Italiano, Deutsch, French

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

COSMED is glad to announce the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+ and Q-NRG, a metabolic monitoring device utilizing Indirect Calorimetry (IC) technology intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing.

August 15, 2019: COSMED and Baxter Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

Posted on 15 August 2019, English, Company, Italiano, Deutsch, French

August 15, 2019: COSMED and Baxter Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

COSMED Srl, a worldwide leader in the design of metabolic systems for clinical and human performance applications and Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced an agreement to commercialize Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry technology.

Optimal Nutrition Care guided by Indirect Calorimetry - COSMED Satellite Symposium at ESICM 2018

Posted on 05 October 2018, Event

indirect calorimetry

The 2018 ESICM (European Society of Intensive Care Medicine) Congress will host a Satellite Symposium sponsored by COSMED dedicated to indirect calorimetry in critically ill patients, including an introduction of the main breakthroughs of the new Q-NRG metabolic monitor.

<<  1 2 [34 5 6 7  >>